CSL Share Price Hits 52-Week Low Despite $1.5 Billion U.S. Expansion and New PAHO Vaccine Deal
CSL Ltd shares closed at a 52-week low of A$141.04 on Thursday, down 1.08% for the day and 18.31% so far this year. The drop continued despite CSL announcing a $1.5 billion U.S. plasma plant expansion and a Latin America vaccine deal this week. Investors remain cautious after February’s profit slump, impairments, and CEO change.